Mitesco (MITI) Capital Expenditures (2011 - 2022)

Mitesco (MITI) reported Capital Expenditures of -$174539.0 for Q4 2022, up 53.1% year-over-year from -$114003.8 in Q4 2021, and down 363722.92% quarter-over-quarter from $48.0 in Q3 2022.

Mitesco (MITI) Capital Expenditures (2011 - 2022) Analysis & Trends

Mitesco (MITI) has 7 years of Capital Expenditures data on file, last reported at -$174539.0 in Q4 2022.

  • Capital Expenditures for Q4 2022 came in at -$174539.0, up 53.1% year-over-year; the trailing twelve-month figure through Sep 2023 was -$174539.0 (up 4.05% YoY), and the FY2022 annual result was $15709.0, down 99.19% from the prior year.
  • Capital Expenditures retreated to -$174539.0 in Q4 2022 per MITI's latest filing, from $48.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $2.3 million in Q3 2021 and troughed at -$372146.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn 1.75 Mn
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 3.67 Mn
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 15.93 Mn
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn 28,000.00
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn 118,000.00
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn 2.25 Mn
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 15.33 Mn
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn -
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn 12.44 Mn
10 Mitesco - - - -

Historic Data

Download Data
DateValue
Dec 31, 2022 -174,539.00
Dec 31, 2022 -174,539.00
Sep 30, 2022 48.00
Sep 30, 2022 48.00
Jun 30, 2022 170,977.00
Jun 30, 2022 170,977.00
Mar 31, 2022 19,223.00
Mar 31, 2022 19,223.00
Dec 31, 2021 -372,146.00
Dec 31, 2021 -372,146.00
Sep 30, 2021 2.30 Mn
Sep 30, 2021 2.30 Mn
Sep 30, 2015 17,914.00
Sep 30, 2015 17,914.00
Jun 30, 2015 25,302.00
Jun 30, 2015 25,302.00
Mar 31, 2015 46,281.00
Mar 31, 2015 46,281.00
Dec 31, 2014 106,513.00
Dec 31, 2014 106,513.00